Madrigal Pharmaceuticals research and development expenses for the twelve months ending December 31, 2024 were $0.237B, a 13.08% decline year-over-year.
Madrigal Pharmaceuticals annual research and development expenses for 2024 were $0.237B, a 13.08% decline from 2023.
Madrigal Pharmaceuticals annual research and development expenses for 2023 were $0.272B, a 10.96% increase from 2022.
Madrigal Pharmaceuticals annual research and development expenses for 2022 were $0.245B, a 19.63% increase from 2021.
Madrigal Pharmaceuticals Research and Development Expenses 2010-2024 | MDGL